The Retrovirology Symposium " On the occasion of semi-retirement of Jonathan Weber & Charles Bangham" supported by Imperial College London and Kumamoto University as part of the JSPS Core-to-Core Program "Integrative approach for normal and leukemic stem cells" was held on July 6th, 2023 at Anthony de Rothschild Lecture Theatre in Imperial College London. The day celebrated the semi-retirement of Professor Jonathan Weber (Dean of the Faculty of Medicine) and Professor Charles Bangham (Co-Director of the Institute of Infection), who first met 60 years ago during their junior school days. Approximately 60 attendees gathered to hear talks on HIV and HTLV-1 given by academics worldwide. Dr. Masao Matsuoka (Kumamoto University) attended the symposium as a speaker. The event provided a retrospective of their collaborative journey, marked by significant contributions to retroviral research.
Please refer to the following URL for the details.
Retrovirology Symposium: A celebration of 60 years of friendship & collaboration | Imperial News | Imperial College London
Click here for the full program.
【Speakers】
Lucy Cook (Imperial College London)
"HTLV-1 & PreClinical Disease"
Graham Taylor (University of Guelph)
"Observations on HTLV from the St Mary's Cohort"
Goedele Maertens (Imperial College London)
"Molecular Insights into the HTLV-1 Integration Machinery and its Interaction with the Host"
Masao Matsuoka (Kumamoto University)
"How HTLV-1 Causes Leukaemia in Humans"
Sarah Fidler (Imperial College London)
"Current Studies Towards a Cure for HIV"
Peter Cherepanov (Imperial College London)
"HIV-1 Integrase as a Target for Drug Development "
Manu Hanon
"The Pandemic Paradox: How the Global Crisis Has Been Driving Innovation in Vaccinology"
Sheena McCormack (University College London)
"The PrEP-PEP Interface: Where Are We Now? "
Clare Jolly (University College London)
"Permissivity & Reprogramming During HIV-1 Infection of T cells "
John Frater (Oxford University)
HIV bNAbs - The Search for the 'Vaccinal Effect'
Aileen Rowan (Imperial College London)
"Pre-malignant Disease in HTLV-1 Carriers: A Rare Chance to Study the Evolution of Cancer in Human"
Paul Bieniasz (Rockfeller University)
"Evading Host Defences - How Viral RNA Avoids Being "ZAP"ed "